if they execute on their conservatives EBITDA growth of 15% puts FY22 EBITDA at $13m.
A 6x multiple puts this at $79m MC. Fairly valued at today’s price. I wouldnt say there is no downside risk. I’d love to get more at around 40-50c
Ann: Appendix 4E and Annual Report for Year Ended 30 June 2021, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $44.49M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 36.5¢ | 36.0¢ | $50.90K | 139.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22203 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 54052 | 3 |
View Market Depth
| Last trade - 14.59pm 24/06/2025 (20 minute delay) ? |
| SEQ (ASX) Chart |